FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer | NobleBlocks

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Public

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

N

Shared by NobleBlocks on Dec 20, 2018 • 12:00 AM UTC

Authors:

Thierry Conroy

,

Pascal Hammel

,

Mohamed Hebbar

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Dec 20, 2018 • 12:00 AM UTC

NobleID:w1/20260526/E4587820

DOI:10.1056/nejmoa1809775

No figures available

Scan for Errors

Scan for EDDII

Summarise

Generate Podcast